Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carlijn C E Jordans"'
Autor:
Klaske J. Vliegenthart-Jongbloed, Marta Vasylyev, Carlijn C. E. Jordans, Jose I. Bernardino, Silvia Nozza, Christina K. Psomas, Florian Voit, Tristan J. Barber, Agata Skrzat-Klapaczyńska, Oana Săndulescu, Casper Rokx
Publikováno v:
Microorganisms, Vol 12, Iss 2, p 254 (2024)
Undiagnosed HIV infection is a prominent clinical issue throughout Europe that requires the continuous attention of all healthcare professionals and policymakers to prevent missed testing opportunities and late diagnosis. This systematic review aimed
Externí odkaz:
https://doaj.org/article/12ce8d5c70df4841b0b001562745aa5b
Autor:
Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, Janneke E. Stalenhoef – Schukken, Anthonius Dofferhoff, Inge Ludwig, Adrianus Koster, Robert-Jan Hassing, Jeannet C. Bos, Geert R. van Pottelberge, Imro N. Vlasveld, Heidi S. M. Ammerlaan, Elena M. van Leeuwen – Segarceanu, Jelle Miedema, Menno van der Eerden, Thijs J. Schrama, Grigorios Papageorgiou, Peter te Boekhorst, Francis H. Swaneveld, Yvonne M. Mueller, Marco W. J. Schreurs, Jeroen J. A. van Kampen, Barry Rockx, Nisreen M. A. Okba, Peter D. Katsikis, Marion P. G. Koopmans, Bart L. Haagmans, Casper Rokx, Bart J. A. Rijnders
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
There are currently no drugs available to treat SARS-CoV-2 infection. A promising alternative treatment for COVID-19 patients is convalescent plasma. Here, Gharbharan et al. collect covalescent plasma and report no overall clinical benefit for 86 pat
Externí odkaz:
https://doaj.org/article/a6dfe323ebd74308ad646da02ba72d20
Autor:
Rachida El Moussaoui, Marion E Vriesde, Casper Rokx, Renée N N Finkenflügel, David A. M. C. van de Vijver, Carlijn C E Jordans, Bart J. A. Rijnders, Kathryn S Hensley, Jan E A van Beek, Annelies Verbon, Elisabeth H. Gisolf, Jeroen J. A. van Kampen, Gonneke Hermanides, Charles A. Boucher, Femke P N Mollema
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(3), 521-524. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(3), 521-524. Oxford University Press
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased disproportionally compared with other non–COVID-19 diseases, which was accompanied by reduced HIV testing rates, number and proportion of positive HIV tests, and
Autor:
Carlijn C E Jordans, Anna Z Mykytyn, Eric C. M. van Gorp, Mart M. Lamers, Corine H. GeurtsvanKessel, Matthijs P. Raadsen, Arvind Gharbharan, Bart J. A. Rijnders, Bart L. Haagmans, Johannes P. C. van den Akker, Petra B. van den Doel, Henrik Endeman, Marco Goeijenbier, Marion Koopmans, Casper Rokx
Publikováno v:
Journal of Clinical Immunology
Journal of Clinical Immunology, 42(2), 232-239. Springer New York
Journal of Clinical Immunology, 42(2), 232-239. Springer New York
Purpose To study the effect of interferon-α2 auto-antibodies (IFN-α2 Abs) on clinical and virological outcomes in critically ill COVID-19 patients and the risk of IFN-α2 Abs transfer during convalescent plasma treatment. Methods Sera from healthy
Autor:
Adam A Anas, Casper Rokx, Marijn Smits-Zwinkels, Bart J. A. Rijnders, Robert-Jan Hassing, Susanne Bogers, C. Ellen van der Schoot, Carlijn C E Jordans, Ilse M.G. Hageman, Anne Marie de Man, Marjolein van der Klift, Maaike Meertens, Francis Swaneveld, Ella C van den Hout, Marc Blaauw, Corine H. GeurtsvanKessel, Arvind Gharbharan
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(7), 1271-1274. Oxford University Press
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 74(7), 1271-1274. Oxford University Press
Twenty-five B-cell–depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutra
Autor:
Mikaela, Smit, Carlijn C E, Jordans, Jitte M, Reinhard, Wichor M, Bramer, Annelies, Verbon, Casper, Rokx, Alexandra, Calmy
Publikováno v:
AIDS (London, England). 36(8)
To understand the impact of clinical decision support systems (CDSSs) on improving HIV testing and diagnosis.An original global systematic review (PROSPERO Number: CRD42020175576) of peer-reviewed articles reporting on electronic CDSSs that generate
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
To reach the UNAIDS target of zero new HIV infections in the Netherlands, timely diagnosis of HIV is essential to enable starting antiretroviral treatment which prevents AIDS and onward transmission. To attain this, optimal HIV testing strategies in
Autor:
Joan-Ramon Grifols, Jaap Jan Zwaginga, Julià Blanco, Pere Millat-Martinez, Anna Ruiz-Comellas, Andrea B. Troxel, Ellen van der Schoot, Bart J. A. Rijnders, Quique Bassat, Geert H. Groeneveld, Rosa Amado Simon, Dan Ouchi, Ignacio Blanco, Nan van Geloven, Corine H. GeurtsvanKessel, Francini Piccolo Ferreira, Bàrbara Baro, Arvind Gharbharan, Grigorios Papageourgiou, Andrea Alemany, Carlijn C E Jordans, Vanesa Garcia Garcia, Jordi Ara, Pierre Malchair, Francis Swaneveld, Casper Rokx, Joana Rodriguez Codina, Bonaventura Clotet, Marc Corbacho-Monné, Sebastián Videla, Oriol Mitjà, Anna Ramirez-Morros
BackgroundConvalescent plasma (CP) for hospitalized patients with COVID-19 has not demonstrated clear benefits. However, data on outpatients with early symptoms are scarce. We aimed to assess whether treatment with CP administered during the first 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54c3d886d3270262e62fe6a12ce42b89
https://doi.org/10.1101/2021.11.30.21266810
https://doi.org/10.1101/2021.11.30.21266810
Autor:
Arvind Gharbharan, Jeannet C. Bos, Peter te Broekhorst, Inge Ludwig, Faiz Karim, Femke P N Mollema, Janneke E. Stalenhoef, Jan G den Hollander, Elena Segarceanu, Jelle R. Miedema, Carlijn C E Jordans, Corine H. GeurtsvanKessel, Imro N. Vlasveld, Geert R. van Pottelberge, Anton S M Dofferhoff, Grigorios Papageorgiou, Bart L. Haagmans, Nisreen M.A. Okba, Marion Koopmans, Heidi S. M. Ammerlaan, Francis H. Swaneveld, Menno M. van der Eerden, Bart J. A. Rijnders, Robert-Jan Hassing, Peter D. Katsikis, Casper Rokx, Ad Koster, Yvonne M. Mueller
Structured abstract for full paperBackgroundAfter recovery from COVID-19, most patients have anti-SARS-CoV-2 neutralizing antibodies. Their convalescent plasma could be an inexpensive and widely available treatment for COVID-19.MethodsThe Convalescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af56feb244e78b0078e2e74bd113a776